NEWARK, Del., July 13, 2026 — The global healthcare industry is witnessing continued growth in demand for advanced anticoagulant therapies as cardiovascular diseases, atrial fibrillation, and venous thromboembolism cases increase worldwide. According to Future Market Insights (FMI), the Rivaroxaban Market is projected to grow from USD 96.54 million in 2026 to USD 107.64 million by 2036,...